Abbott
The pharma giant is collaborating with sports tech firm Supersapiens.
The updated version of the company's system includes automatic alerts when the wearer's glucose is too high or too low.
Also: Abbott sells 150 million of its rapid, app-paired COVID-19 test to the White House; Platform launches for chronic disease patients juggling multiple providers.
Users are also able to access a corresponding app, which can keep track of their coronavirus test results.
Also: Dexcom continues to make strides, while iRhythm Technologies takes a hit in Q2.
The Patient Controller app works with Abbott's Infinity DBS System, Proclaim XR SCS System and Proclaim DRG Neurostimulation System.
The new devices can link to the MyMerlinPulse app and give doctors information about a patient's heart health.
Walgreens Boots Alliance expanded its partnership with Microsoft and Adobe to launch a digital platform that will deliver personalized healthcare and shopping offerings.
The system is able to continuously transmit glucose data every minute.
From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.